Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Barry

Showing results (341-350 of 420) with videos related to

Pageof 42
Sort By:
American Journal of Clinical Pathology|December 1, 1978
Reassessment of the "class" concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporinsA L Barry, C Thornsberry, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1995
Tentative criteria for determining the in vitro susceptibilities of Haemophilus influenzae, including quality control parameters, to two fluoroquinolones (grepafloxacin and PD 131628)D L Sewell, A L Barry, S D Allen, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1980
Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibioticsR N Jones, C Thornsberry, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1977
Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalothin against 5,887 clinical bacterial isolatesR N Jones, P C Fuchs, T L Gavan, et al.
The American Journal of the Medical Sciences|November 1, 1977
Ticarcillin: a collaborative in vitro comparison with carbenicillin against over 9,000 clinical bacterial isolatesP C Fuchs, T L Gavan, E H Gerlach, et al.
Journal of Clinical Microbiology|November 1, 1988
Variability of clarithromycin and erythromycin susceptibility tests with Haemophilus influenzae in four different broth media and correlation with the standard disk diffusion testA L Barry, P B Fernandes, J H Jorgensen, et al.
Journal of Clinical Microbiology|January 1, 1987
Quality control limits for microdilution susceptibility tests with norfloxacinA L Barry, T L Gavan, L W Ayers, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1981
Antibacterial activity of fortimicin A compared with those of five other aminoglycosides, and factors affecting susceptibility testsC Thornsberry, A L Barry, R N Jones, et al.
American Journal of Clinical Pathology|October 1, 1979
Cefaclor and cefatrizine, new investigational orally administered cephalosporins. In-vitro collaborative evaluation against clinical bacterial isolates and comparison with related antimicrobicsR N Jones, P C Fuchs, C Thornsberry, et al.
European Journal of Clinical Microbiology|February 1, 1986
In vitro activity of the aryl-fluoroquinolones A-56619 and A-56620 and evaluation of disk susceptibility testsA L Barry, R N Jones, C Thornsberry, et al.
Pageof 42

Showing results (341-350 of 420) with videos related to

Sort By:
Pageof 42
American Journal of Clinical Pathology|December 1, 1978
Reassessment of the "class" concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporinsA L Barry, C Thornsberry, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1995
Tentative criteria for determining the in vitro susceptibilities of Haemophilus influenzae, including quality control parameters, to two fluoroquinolones (grepafloxacin and PD 131628)D L Sewell, A L Barry, S D Allen, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1980
Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibioticsR N Jones, C Thornsberry, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1977
Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalothin against 5,887 clinical bacterial isolatesR N Jones, P C Fuchs, T L Gavan, et al.
The American Journal of the Medical Sciences|November 1, 1977
Ticarcillin: a collaborative in vitro comparison with carbenicillin against over 9,000 clinical bacterial isolatesP C Fuchs, T L Gavan, E H Gerlach, et al.
Journal of Clinical Microbiology|November 1, 1988
Variability of clarithromycin and erythromycin susceptibility tests with Haemophilus influenzae in four different broth media and correlation with the standard disk diffusion testA L Barry, P B Fernandes, J H Jorgensen, et al.
Journal of Clinical Microbiology|January 1, 1987
Quality control limits for microdilution susceptibility tests with norfloxacinA L Barry, T L Gavan, L W Ayers, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1981
Antibacterial activity of fortimicin A compared with those of five other aminoglycosides, and factors affecting susceptibility testsC Thornsberry, A L Barry, R N Jones, et al.
American Journal of Clinical Pathology|October 1, 1979
Cefaclor and cefatrizine, new investigational orally administered cephalosporins. In-vitro collaborative evaluation against clinical bacterial isolates and comparison with related antimicrobicsR N Jones, P C Fuchs, C Thornsberry, et al.
European Journal of Clinical Microbiology|February 1, 1986
In vitro activity of the aryl-fluoroquinolones A-56619 and A-56620 and evaluation of disk susceptibility testsA L Barry, R N Jones, C Thornsberry, et al.
Pageof 42